Completion of the Icatibant Outcome Survey and What We Learned

20260 citationsJournal Articlehybrid Open Access

Authors

Laurence Bouillet · Centre Hospitalier Universitaire de Grenoble

Werner Aberer · Medical University of Graz

T. Caballero · Hospital La Paz Institute for Health Research

Anete S. Grumach · Faculdade de Medicina do ABC

Hilary J. Longhurst · Auckland City Hospital

Alissa Dangel · Takeda (United States)

Natalie Khutoryansky

Abstract

Summary The Icatibant Outcome Survey observational registry began in 2009 to monitor the safety and effectiveness of icatibant. Fifteen years of icatibant use support effectiveness in hereditary angioedema, with no new safety signals.

Topics & Keywords

Coagulation, Bradykinin, Polyphosphates, and Angioedema Complement system in diseases Hemophilia Treatment and Research

Publication Details

Published in: Clinical & Experimental Allergy

DOI: 10.1111/cea.70271

Field-Weighted Citation Impact: 0.00

Command Palette

Completion of the Icatibant Outcome Survey and What We Learned

Authors

Abstract

Topics & Keywords

Publication Details